Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Total Debt (2010 - 2018)

Vericel (VCEL) posted Total Debt of $17.3 million for Q3 2018, little changed sequentially from $17.3 million in Q2 2018, and up 73.55% YoY from $10.0 million in Q3 2017.

Analysis

Vericel (VCEL) Total Debt (2010 - 2018) Analysis & Trends

Vericel has reported Total Debt for 9 years, with the latest figure at $17.3 million in Q3 2018.

  • Quarterly Total Debt rose 73.55% year-over-year to $17.3 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $17.3 million (up 73.55% YoY) and the FY2017 annual result came in at $17.2 million, up 2025.52% from the prior year.
  • Total Debt steadied at $17.3 million in Q3 2018 per VCEL's latest filing, from $17.3 million in the prior quarter.
  • Over five years, Total Debt peaked at $17.3 million in Q3 2018 and troughed at $2000.0 in Q1 2014.
  • A 5-year average of $5.8 million and a median of $1.7 million in 2014 frame the typical range for Total Debt.
  • The sharpest annual moves came in 2015 and 2017: Total Debt sank 96.36% in 2015, then soared 19423.08% in 2017.
  • Over 5 years, Total Debt stood at $457000.0 in 2014, then tumbled by 84.46% to $71000.0 in 2015, then surged by 1042.25% to $811000.0 in 2016, then surged by 2025.52% to $17.2 million in 2017, then gained by 0.24% to $17.3 million in 2018.
  • According to Business Quant data, Total Debt over the past three periods registered $17.3 million, $17.3 million, and $17.2 million for Q3 2018, Q2 2018, and Q1 2018 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 591.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.07 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 9.34 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 546.77 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 17.28 Mn
Jun 30, 2018 18.81 Mn
Mar 31, 2018 19.17 Mn
Dec 31, 2017 18.25 Mn
Sep 30, 2017 11.23 Mn
Jun 30, 2017 10.36 Mn
Mar 31, 2017 10.78 Mn
Dec 31, 2016 1.57 Mn
Sep 30, 2016 6.27 Mn
Jun 30, 2016 52,000.00
Mar 31, 2016 62,000.00
Dec 31, 2015 828,000.00
Sep 30, 2015 81,000.00
Jun 30, 2015 91,000.00
Mar 31, 2015 100,000.00
Dec 31, 2014 457,000.00
Sep 30, 2014 1.72 Mn
Jun 30, 2014 5.00 Mn
Mar 31, 2014 2,000.00
Dec 31, 2013 12,000.00